ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Colorcon Ventures Invests in i20 Therapeutics contractpharma
December 08, 2020?i2O Therapeutics, a biotech company developing a platform to enable oral delivery of traditionally injectable biological drugs, has received a strategic investment from Colorcon Ventures, the corporate venture fund of Colorcon Inc.
Pharma Sources Insight January 2025
